HKSE · 0512.HK
Grand Pharmaceutical Group Limited
HK$4.31-HK$0.01 (-0.23%)
Grand Pharmaceutical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 51.46% below the high.
Loading market information…
HKSE · 2235.HK · HKD
Stock price, earnings
Quote as of Oct 30, 2026, 07:45 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
MicroTech Medical (Hangzhou) Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 19.08% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
MicroTech Medical (Hangzhou) Co., Ltd.’s next earnings report is currently expected on Mar 31, 2027, with estimated earnings per share of HK$0.16. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow MicroTech Medical (Hangzhou) Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
MicroTech Medical (Hangzhou) Co., Ltd. focuses on the innovation, production, and market distribution of essential medical devices and consumables for diabetes management. Its operations extend across the People's Republic of China and into global markets. The company offers a comprehensive range of products, including the Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, traditional blood glucose monitoring systems, and advanced closed-loop artificial pancreas technology. Beyond its core offerings, MicroTech Medical is also actively involved in engineering and technological research, experimentation, and developmental endeavors. The firm, established in 2011, maintains its headquarters in Hangzhou, People's Republic of China.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:16 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| HK$161.96M-2.13% vs estimate |
| Q4 2023 | Mar 28, 2024 | -HK$0.28-259.12% vs estimate | HK$157.62M-60.87% vs estimate |
|---|
| Q2 2023 | Aug 30, 2023 | -HK$0.05-9.67% vs estimate | HK$119.84M+1.69% vs estimate |
|---|
| Q4 2022 | Mar 28, 2023 | -HK$0.07+32.72% vs estimate | HK$115.92M-60.52% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$4.31-HK$0.01 (-0.23%)
Grand Pharmaceutical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 51.46% below the high.
HK$1.47-HK$0.08 (-5.16%)
LifeTech Scientific Corporation’s quoted price sits in the lower half of its reported 52-week range, 38.24% below the high.
HK$11.74-HK$0.54 (-4.4%)
China Isotope & Radiation Corporation’s quoted price sits in the lower half of its reported 52-week range, 53.04% below the high.
HK$6.22+HK$0.07 (+1.14%)
Medcaptain Medical Technology Co. Ltd. Class H’s quoted price sits in the lower half of its reported 52-week range, 42.94% below the high.
HK$3.77-HK$0.15 (-3.83%)
Peijia Medical Limited’s quoted price sits in the lower half of its reported 52-week range, 48.85% below the high.
HK$5.22-HK$0.36 (-6.37%)
Acotec Scientific Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 65.93% below the high.
HK$0.90+HK$0.03 (+2.87%)
PW Medtech Group Limited’s quoted price sits in the lower half of its reported 52-week range, 41.12% below the high.
HK$1.81+HK$0.01 (+0.56%)
Sisram Medical Ltd’s quoted price sits in the lower half of its reported 52-week range, 63.24% below the high.
